These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 6231438

  • 21. Cross resistance of quinolone derivatives in gram-negative bacteria.
    Barba D, Pennucci C, Esposito S, Galante D.
    Chemioterapia; 1985 Apr; 4(2):192-6. PubMed ID: 3159488
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Comparative activities of AM-715 and pipemidic and nalidixic acids against experimentally induced systemic and urinary tract infections.
    Hirai K, Ito A, Abe Y, Suzue S, Irikura T, Inoue M, Mitsuhashi S.
    Antimicrob Agents Chemother; 1981 Jan; 19(1):188-9. PubMed ID: 6454381
    [Abstract] [Full Text] [Related]

  • 25. Study of the in vitro activity of norfloxacin and other drugs on amoxicillin-resistant uropathogenic isolates.
    Piccolomini R, Allocati N, Catamo G.
    Chemioterapia; 1984 Jun; 3(3):167-72. PubMed ID: 6241505
    [Abstract] [Full Text] [Related]

  • 26. In vitro synergism of nalidixic acid with other broad spectrum antibiotics.
    Piccolomini R, Cellini L, Allocati N, Ravagnan G.
    Chemioterapia; 1984 Apr; 3(2):103-7. PubMed ID: 6532536
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Comparison of the antibacterial in vitro and in vivo activity of ofloxacin (HOE 280 DL 8280) and nalidixic acid analogues.
    Seibert G, Limbert M, Klesel N.
    Eur J Clin Microbiol; 1983 Dec; 2(6):548-53. PubMed ID: 6230226
    [Abstract] [Full Text] [Related]

  • 29. Rapid selection of organisms with increasing resistance on subinhibitory concentrations of norfloxacin in agar.
    Tenney JH, Maack RW, Chippendale GR.
    Antimicrob Agents Chemother; 1983 Jan; 23(1):188-9. PubMed ID: 6219620
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Effects of changes in pH, medium and inoculum size on the in vitro activity of different quinolone and fluoroquinolone antibiotics against urinary pathogens.
    Gesu GP, Eftimiadi C, Debbia E, Schito GC.
    Drugs Exp Clin Res; 1987 Jan; 13(2):79-84. PubMed ID: 3556122
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Norfloxacin: activity against urinary tract pathogens and factors influencing the emergence of resistance.
    Greenwood D, Osman M, Goodwin J, Cowlishaw WA, Slack R.
    J Antimicrob Chemother; 1984 Apr; 13(4):315-23. PubMed ID: 6233248
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.